Nxera Pharma Shares Video Interviews with Major Shareholders on Its Official YouTube Channel

Core Insights - Nxera Pharma Co., Ltd. has released video interviews with major shareholders to provide insights into their investment views and confidence in the Company's strategy [1][2] - The interviews feature Mr. Yoshiharu Asai from JIC Venture Growth Investments and Mr. Daisuke Gomi, an individual shareholder, discussing Nxera's strategy and operations [3][4] Company Overview - Nxera Pharma is a technology-powered biopharma company focused on developing specialty medicines for unmet medical needs in Japan and globally [6] - The Company has established a new-generation commercial business in Japan, aiming to develop and commercialize innovative medicines [6] Investment Perspectives - The interviews aim to enhance understanding of Nxera's corporate strategy and business initiatives among stakeholders [4] - Key topics discussed include the background of investment in Nxera, valuation approaches, and notable pipeline programs [7][8] Pipeline and Focus Areas - Nxera is advancing over 30 active programs through its NxWave™ discovery platform, targeting major unmet needs in obesity, metabolic disorders, neurology, and immunology [9] - The Company employs approximately 400 people across key locations, including Tokyo, Osaka, London, Cambridge, Basel, and Seoul [10]